Safeguard Scientifics, Inc. Appoints Eric Salzman as Chief Restructuring Officer
April 06, 2020 at 07:04 am EDT
Share
On March 30, 2020, the Safeguard Scientifics, Inc. entered into an employment agreement with Eric Salzman. The Salzman Agreement provides for the terms and conditions of Mr. Salzman's employment with the Company and his appointment, effective as of April 1, 2020, as the Company's Chief Restructuring Officer. Mr. Salzman, had been providing consulting services to the Company since November 21, 2019. Mr. Salzman has over 25 years of experience in M&A, restructuring and special situations investing at several firms including Credit Suisse Asset Management and Lehman Brothers. Most recently, Mr. Salzman has been the Managing Member of SarniHaan Capital Partners LLC.
Safeguard Scientifics, Inc. is a provider of capital and relevant expertise to technology-driven businesses. The Company offers strategic, operational and management support to certain of its ownership interests, which include defining short and long-term strategic goals; identifying and planning for the critical success factors to reach these goals; identifying and addressing the challenges and operational improvements required to achieve the critical success factors and, ultimately, the strategic goals; identifying and implementing the business measurements that the Company and others are apply to measure a companyâs success; and identifying sources of and providing capital to drive growth. It also continues to hold relatively small equity interests in other enterprises where it does not exert significant influence and do not participate in management activities. The Company's subsidiaries include Bonfield VII, Ltd., Safeguard Delaware, Inc., SFE Properties, Inc., and others.